Vicki Kiesel
CEO & Founder, Genetic Experts
About Vicki
Vicki Kiesel is the CEO and founder of Genetic Experts and one of the UK’s leading specialists in cancer genomics and genetic counselling. With more than 20 years of clinical experience, she is recognised nationally for her expertise, strategic leadership, and commitment to ethical, clinically actionable genomic medicine.
She is the Chair of the Genomics Expert Advisory Group for the East Midlands Cancer Alliance and Lead Genetic Counsellor for the LNR Genomic Service, where she has shaped regional and national approaches to hereditary cancer testing.
As the East Genomics Lynch Syndrome Lead, Vicki has driven the successful implementation of Lynch syndrome testing across the East Midlands — work highlighted internationally through the NHS England National Lynch Syndrome Transformation Project:
She supported the development of the Lynch Choices decision aid, supporting individuals with Lynch syndrome to make informed choices about risk-reducing interventions:
Vicki also contributed to the creation of the National Fragile X Hub at Leicester:
Before founding Genetic Experts, Vicki led a national team of genetic counsellors at Genehealth UK (2014–2021) and previously led the North West Thames Regional Genetic Counselling Service.
She lectures at the University of Leicester, teaches cancer risk assessment to allied health professionals, mentors genetic counsellors across the UK, and serves as a GCRAB assessor and expert witness in genetics.
Her contributions have been recognised internationally, including receiving the Beth Fine Best Student Abstract Award from the National Society of Genetic Counselors:
Vicki has also acted as a medical advisor for BBC drama and appeared on multiple television and radio programmes, including Doctor in the House and DNA Family Secrets:
Charity & Public Engagement
Cancer Charity Advisory Work
Vicki has advised several UK cancer charities on hereditary cancer testing, risk assessment, and patient decision support. Her contributions include shaping educational materials, supporting charity-led awareness campaigns, and advising on clinical best practice.
BBC Public Education & Outreach
Through her work as a medical advisor for BBC drama and factual programming, Vicki has helped ensure accurate representation of genetic testing and hereditary cancer. Her appearances on DNA Family Secrets and Doctor in the House have supported public understanding of genomics and inherited conditions.
National Fragile X Hub
Vicki contributed to the development of the National Fragile X Hub, supporting families affected by Fragile X syndrome.
View Discovery DocumentLynch Syndrome Public Engagement
Her leadership in the NHS England Lynch Syndrome Transformation Project includes public-facing work with patient groups, charities, and advocacy organisations to improve awareness and access to testing.
Transformation ProjectProfessional Bodies
- AGNC (Association of Genetic Nurses and Counsellors)
Working parties, professional development, national training - GCRAB
Voluntary assessor roles - NSHCS
Training officer roles supporting genomic counselling trainees
Charity-Linked Events & Public Talks
- Royal Society of Medicine – Breast Cancer Forum
- East Genomics Cancer Showcase
Publications
Selected Peer-Reviewed Publications
Recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes: a UK Cancer Genetics Group consensus meeting
Christopher J, Edgerley K, McIldowie B Consensus meeting attendees, et al. Journal of Medical Genetics 2026;63:57-63.
Recontact and follow-up for hereditary breast and ovarian cancer gene carriers (J Med Genet, 2025)
Optimising risk-reducing surgery and aspirin decision aids for Lynch syndrome (J Genet Couns, 2025)
Management of unexplained mismatch repair deficiency (u-dMMR) (J Med Genet, 2024)
ABS–UKCGG–CanGene–CanVar consensus on the use of CanRisk (Br J Cancer, 2024)
Psychosocial impact of prostate cancer screening for BRCA1/2 carriers (BJU Int, 2024)
Serum testosterone and prostate cancer in BRCA1/2 carriers (BJUI Compass, 2023)
Systematic review of patient decision support resources in cancer genetics (Front Health Serv, 2023)
The value of genetic counselling in breast cancer genetic testing (EJSO, 2020)
IMPACT Study — targeted prostate cancer screening in BRCA1/2 carriers (Eur Urol, 2014; BJU Int, 2011)
Cancer risk assessment and communicating risk — OUP textbook chapter
Ready to arrange a consultation?
Book an initial consultation to discuss your personal and family medical history with one of our expert genetic counsellors.
Book Your Initial Consultation